CLINICAL TRIALS PROFILE FOR MICRONOR
✉ Email this page to a colleague
All Clinical Trials for MICRONOR
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT03106454 ↗ | Ovulation Incidence in Oral Contraceptive Users | Unknown status | Society of Family Planning | Phase 3 | 2014-08-01 | Since the introduction of the combined hormonal contraceptive pill, dosages of ethinyl estradiol (EE) have steadily decreased from more than 150mcg to 20mcg in an attempt to improve the risk profile associated with the COC. In 2010, the Food and Drug Administration approved a oral contraceptive pill containing EE 10mcg/NET acetate 1mg (Tradename Lo loestrin). However, no studies have compared this formulation to pills containing either higher doses of estrogen or progestin alone. It is not known whether EE 10mcg is sufficient to prevent follicular development or to support the endometrium as well as higher doses of EE. This trial addresses the question of whether an oral contraceptive pill with EE 10mcg/Norethindrone acetate 1mg will better suppress ovulation or have a better side effect profile than a progestin only pill with a nearly equal dose of norethindrone. |
| NCT03106454 ↗ | Ovulation Incidence in Oral Contraceptive Users | Unknown status | University of Southern California | Phase 3 | 2014-08-01 | Since the introduction of the combined hormonal contraceptive pill, dosages of ethinyl estradiol (EE) have steadily decreased from more than 150mcg to 20mcg in an attempt to improve the risk profile associated with the COC. In 2010, the Food and Drug Administration approved a oral contraceptive pill containing EE 10mcg/NET acetate 1mg (Tradename Lo loestrin). However, no studies have compared this formulation to pills containing either higher doses of estrogen or progestin alone. It is not known whether EE 10mcg is sufficient to prevent follicular development or to support the endometrium as well as higher doses of EE. This trial addresses the question of whether an oral contraceptive pill with EE 10mcg/Norethindrone acetate 1mg will better suppress ovulation or have a better side effect profile than a progestin only pill with a nearly equal dose of norethindrone. |
| NCT04965116 ↗ | Progestin-Only Pill Use and Breastfeeding Study | Recruiting | University of California, San Diego | Phase 4 | 2021-09-28 | This study will assess the impact of early initiation (less than one week postpartum) and delayed initiation (4 weeks postpartum) of two types of progestin-only contraceptive pills (POPs) on maternal, breastmilk, and infant outcomes. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MICRONOR
Condition Name
Clinical Trial Locations for MICRONOR
Trials by Country
Clinical Trial Progress for MICRONOR
Clinical Trial Phase
Clinical Trial Sponsors for MICRONOR
Sponsor Name
